NIH to Launch New On-Line Repository for Life Sciences Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 10
Volume 8
Issue 10

BETHESDA, Md-The new year will bring a new and controversial source for obtaining access to new scientific studies in the life sciences. In January, the National Institutes of Health (NIH) will launch PubMed Central, a free on-line repository of research reports, found at http://www.ncbi.nlm.nih.gov/PubMed/.

BETHESDA, Md—The new year will bring a new and controversial source for obtaining access to new scientific studies in the life sciences. In January, the National Institutes of Health (NIH) will launch PubMed Central, a free on-line repository of research reports, found at http://www.ncbi.nlm.nih.gov/pubmed/.

The site will store, organize, and distribute articles, preprints, and screened reports contributed to the repository by scientific journals and “reputable scientific organizations.” It is unclear, however, to what extent peer-reviewed journals will cooperate with the new venture.

PubMed Central is an expanded form of E-biomed, which NIH director Harold E. Varmus, MD, originally proposed in May as a cyberspace library for the biomedical sciences. His idea drew considerable criticism from companies and organizations that publish scientific journals, which feared the free service would cost them subscribers. The plan was also criticized for the use of materials that were not peer reviewed.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.